Adaptive Biotechnologies
Price & Volume
Stats
See moreOpen | $16.41 |
Previous Close | $16.21 |
Day Range | $15.77-$16.48 |
52W Range | $6.25-$20.76 |
Market Cap | $2.4B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $276.9M |
Revenue Growth (YoY) | 51% |
Gross Profit (12 Mos) | $111.8M |
Diluted EPS | -$0.39 |
News
See moreYahoo Finance • 11 days ago
Strong Rare Disease Pipeline Drives Favorable Sentiment for Ultragenyx (RARE)
Yahoo Finance • 21 days ago
Adaptive Biotechnologies Corp (ADPT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth ...
Yahoo Finance • 2 months ago
Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
Yahoo Finance • 2 months ago
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
About
CEO | Mr. Chad M. Robins M.B.A. |
CFO | Mr. Kyle Piskel |
Address | 1165 Eastlake Avenue East, Seattle, WA, United States, 98109 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 619 |
